Literature DB >> 10864525

Isolated systolic hypertension: a radical rethink. It's a risk factor that needs treatment, especially in the over 50s.

I B Wilkinson, D J Webb Christison, J R Cockcroft.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864525      PMCID: PMC1127462          DOI: 10.1136/bmj.320.7251.1685

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  8 in total

1.  Pulse pressure: Is this a clinically useful risk factor?

Authors:  M O'Rourke; E D Frohlich
Journal:  Hypertension       Date:  1999-09       Impact factor: 10.190

2.  Identification and management of stroke risk in older people: a national survey of current practice in primary care.

Authors:  W G Coppola; P H Whincup; M Walker; S Ebrahim
Journal:  J Hum Hypertens       Date:  1997-03       Impact factor: 3.012

3.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

4.  Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study.

Authors:  S S Franklin; W Gustin; N D Wong; M G Larson; M A Weber; W B Kannel; D Levy
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

5.  Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study.

Authors:  S S Franklin; S A Khan; N D Wong; M G Larson; D Levy
Journal:  Circulation       Date:  1999-07-27       Impact factor: 29.690

6.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

Review 7.  Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.

Authors:  L Ramsay; B Williams; G Johnston; G MacGregor; L Poston; J Potter; N Poulter; G Russell
Journal:  J Hum Hypertens       Date:  1999-09       Impact factor: 3.012

8.  MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13
  8 in total
  7 in total

1.  Isolated systolic hypertension. Is it time for me to retire from medicine?

Authors:  A J Jablánczy
Journal:  BMJ       Date:  2000-10-21

Review 2.  Isolated systolic hypertension as a treatable risk factor.

Authors:  P A van Zwieten
Journal:  Neth Heart J       Date:  2002-01       Impact factor: 2.380

3.  Ambulatory blood pressure monitoring profile as a useful prognostic tool in patients with primary hypertension.

Authors:  A L Mohamed; E Katiman; J Abu Hassan
Journal:  Malays J Med Sci       Date:  2003-07

4.  Isolated Systolic Hypertension and its Determinants - A Cross-sectional Study in the Adult Population of Lucknow District in North India.

Authors:  Tanu Midha; Mz Idris; Rk Saran; Ak Srivastava; Sk Singh
Journal:  Indian J Community Med       Date:  2010-01

Review 5.  Issues in the perioperative management of the elderly patient with cardiovascular disease.

Authors:  John W Sear; Helen Higham
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 6.  Optimal drug treatment of systolic hypertension in the elderly.

Authors:  Giuseppe Pannarale
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

7.  Diastolic Augmentation Index Improves Radial Augmentation Index in Assessing Arterial Stiffness.

Authors:  Yang Yao; Liling Hao; Lisheng Xu; Yahui Zhang; Lin Qi; Yingxian Sun; Benqiang Yang; Frans N van de Vosse; Yudong Yao
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.